Protocol with Progestin-primed Ovarian Stimulation (PPOS) in conventional treatment from the start of stimulation vs protocol with GnRH antagonists as a pituitary suppressor in patients who are going to undergo DUOSTIM with embryo accumulation for PGT-A of the embryos.
Phase 1
- Conditions
- Female infertilityTherapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
- Registration Number
- CTIS2023-508769-33-00
- Lead Sponsor
- Ginefiv S.L.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 144
Inclusion Criteria
1.Age less than 43 years . 2.Regular menstrual cycles between 21 and 35 days. 3.Indication for IVF with PGT-A 4. Both ovaries present. 5. Ability to participate and complete the study. 6. Give and sign consent to participate in the study.
Exclusion Criteria
1.Endometriosis grade III/IV 2.Concurrent participation in another study
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method